64 related articles for article (PubMed ID: 11003860)
1. [Neonatal cerebral thrombosis and deficit of factor V leiden].
Moliner Calderón E; López Bernal E; Ginovart Galiana G; Nadal Amat J; Cubells Riero J
An Esp Pediatr; 2000 Jan; 52(1):52-5. PubMed ID: 11003860
[TBL] [Abstract][Full Text] [Related]
2. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
Kurkowska-Jastrzebska I; Wicha W; Dowzenko A; Vertun-Baranowska B; Pytlewski A; Bogusławska R; Członkowska A
Med Sci Monit; 2003 May; 9(5):CS41-5. PubMed ID: 12761462
[TBL] [Abstract][Full Text] [Related]
3. Cerebral venous thrombosis, intraventricular haemorrhage and white matter lesions in a preterm newborn with factor V (Leiden) mutation.
Ramenghi LA; Gill BJ; Tanner SF; Martinez D; Arthur R; Levene MI
Neuropediatrics; 2002 Apr; 33(2):97-9. PubMed ID: 12075492
[TBL] [Abstract][Full Text] [Related]
4. Cerebral sinus thrombosis in a child with active ulcerative colitis and factor V Leiden.
Robison NJ; Dawlabani N; Lastra CR; Dhall G
Pediatr Blood Cancer; 2009 Jul; 52(7):867-9. PubMed ID: 19260108
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
6. [Status of hereditary hypercoagulability and cerebral venous thrombosis. Report of 3 cases].
Guevara C; Nogales-Gaete J; Figueroa T; Sáez D; Valenzuela D
Rev Med Chil; 2002 Jan; 130(1):79-85. PubMed ID: 11961966
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
[TBL] [Abstract][Full Text] [Related]
8. The prevalence of factor V Leiden as a risk factor for venous thromboembolism in the population of North-Western Greece.
Ioannou HV; Mitsis M; Eleftheriou A; Matsagas M; Nousias V; Rigopoulos C; Vartholomatos G; Kappas AM
Int Angiol; 2000 Dec; 19(4):314-8. PubMed ID: 11305729
[TBL] [Abstract][Full Text] [Related]
9. Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.
Chopra N; Koren S; Greer WL; Fortin PR; Rauch J; Fortin I; Senécal JL; Docherty P; Hanly JG
J Rheumatol; 2002 Aug; 29(8):1683-8. PubMed ID: 12180730
[TBL] [Abstract][Full Text] [Related]
10. [Changes in hemostasis system in patients with hereditary thrombophilia caused by mutation of blood coagulation factor V ( factor V Leiden)].
Papaian LP; Kobilianskaia VA; Sheĭdina AM; Baranovskaia SS; Sirotkina OV; Kargin VD; Saltykova NB; Beliazo OE; Golovina OG; Papaian KA; Tarkovskaia LR
Ter Arkh; 2001; 73(7):47-51. PubMed ID: 11523408
[TBL] [Abstract][Full Text] [Related]
11. Isolated internal cerebral venous thrombosis in a neonate with increased lipoprotein (a) level: diagnostic and therapeutic considerations.
Friese S; Müller-Hansen I; Schöning M; Nowak-Göttl U; Küker W
Neuropediatrics; 2003 Feb; 34(1):36-9. PubMed ID: 12690566
[TBL] [Abstract][Full Text] [Related]
12. Factor V Leiden, prothrombin G20210A, and protein C mutation frequency in Turkish venous thrombosis patients.
Altinisik J; Ates O; Ulutin T; Cengiz M; Buyru N
Clin Appl Thromb Hemost; 2008 Oct; 14(4):415-20. PubMed ID: 18160601
[TBL] [Abstract][Full Text] [Related]
13. [Factor V Leiden mutation as a cause of venous thrombosis].
Lobato-Salinas Z; Cambra-Lasaosa FJ; Campistol J; Toll-Costa T; Pons-Odena M; Palomeque-Rico A; Martín JM
Rev Neurol; 2004 Jan 16-31; 38(2):136-9. PubMed ID: 14752712
[TBL] [Abstract][Full Text] [Related]
14. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction.
Middendorf K; Göhring P; Huehns TY; Seidel D; Steinbeck G; Nikol S
Am Heart J; 2004 May; 147(5):897-904. PubMed ID: 15131548
[TBL] [Abstract][Full Text] [Related]
16. Natural coagulation inhibitory proteins and activated protein C resistance in Turkish patients with inflammatory bowel disease.
Payzin B; Adakan FY; Yalçin HC; Cetinkaya GS; Berkmen S; Eraslan S; Unsal B
Turk J Gastroenterol; 2006 Sep; 17(3):183-90. PubMed ID: 16941251
[TBL] [Abstract][Full Text] [Related]
17. [Thrombosis of the cavernous sinus following prone-position spinal surgery in a patient with factor V Leiden].
Casado-Menéndez I; González-Rodríguez C; Díaz-González M; Gómez Díaz-Castroverde A; Fayad M; de la Cruz R
Rev Neurol; 2009 Mar 16-31; 48(6):297-300. PubMed ID: 19291653
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of thrombophilia in women with severe ovarian hyperstimulation syndrome and cost-effectiveness of screening.
Fábregues F; Tàssies D; Reverter JC; Carmona F; Ordinas A; Balasch J
Fertil Steril; 2004 Apr; 81(4):989-95. PubMed ID: 15066453
[TBL] [Abstract][Full Text] [Related]
19. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
Reitsma PH; van de Stolpe A
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
[TBL] [Abstract][Full Text] [Related]
20. An overview of methods for detection of factor V Leiden and the prothrombin G20210A mutations.
Cooper PC; Rezende SM
Int J Lab Hematol; 2007 Jun; 29(3):153-62. PubMed ID: 17474891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
